Extended analysis of sarcomas from the TCGA archive and matched for both (MYC and PTEN) molecular alterations detected in this patient, revealed a constitutive STAT3 expression (absent in MYC amplified tumors), as also identified in prostate tumors [75]. The gene discussed is MYC; the disease is prostate neoplasm.